Subtopic Deep Dive
Survival Outcomes Male Breast Cancer
Research Guide
What is Survival Outcomes Male Breast Cancer?
Survival Outcomes Male Breast Cancer examines prognostic factors, stage-specific survival rates, and long-term outcomes in male patients post-diagnosis, often incorporating molecular subtypes for prediction models.
Studies analyze population-based survival data comparing males to females, highlighting worse overall survival despite similar lymph node-adjusted rates (Giordano et al., 2004; 776 citations). Key papers report 5-year overall survival rates lower in males, influenced by advanced stage at diagnosis (Anderson et al., 2009; 479 citations). Research spans over 20 papers with 200+ citations each, using SEER database and international registries.
Why It Matters
Survival data guide clinical guidelines for male breast cancer treatment, informing tamoxifen use and mastectomy decisions (Giordano et al., 2004). Population studies reveal higher mortality risks in males due to diagnostic delays, impacting patient counseling on prognosis (Anderson et al., 2009; Miao et al., 2011). These outcomes shape public health strategies for rare cancers, improving early detection protocols (Konduri et al., 2020).
Key Research Challenges
Small Sample Sizes
Male breast cancer rarity limits statistical power in single-institution studies, leading to unreliable survival estimates (Giordano et al., 2004). Population registries like SEER help but face underreporting issues. Multi-center efforts like EORTC program address this partially (Cardoso et al., 2017).
Stage at Diagnosis Bias
Males present at advanced stages more often, confounding survival comparisons with females (Anderson et al., 2009). Anatomic factors delay detection despite small tumor sizes (Joshi et al., 1996). Prognostic models struggle to adjust for this consistently.
Molecular Subtype Data Gaps
Limited molecular profiling in males hinders subtype-specific survival predictions (Cardoso et al., 2017). Unlike females, ER-positive dominance lacks HER2-enriched data. Prediction models require larger cohorts for validation.
Essential Papers
Breast carcinoma in men
Sharon H. Giordano, Deborah S. Cohen, Aman U. Buzdar et al. · 2004 · Cancer · 776 citations
Abstract BACKGROUND Male breast carcinoma is an uncommon disease, and most previous studies have been single‐institution series that were limited by extremely small sample sizes. The goals of the c...
Male Breast Cancer: A Population-Based Comparison With Female Breast Cancer
William F. Anderson, Ismail Jatoi, Julia Tse et al. · 2009 · Journal of Clinical Oncology · 479 citations
Purpose Because of its rarity, male breast cancer is often compared with female breast cancer. Patients and Methods To compare and contrast male and female breast cancers, we obtained case and popu...
Epidemiology of male breast cancer
Santhi D. Konduri, Maharaj Singh, George C. Bobustuc et al. · 2020 · The Breast · 399 citations
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
Fátima Cardoso, John M.S. Bartlett, Leen Slaets et al. · 2017 · Annals of Oncology · 379 citations
Breast cancer risk factors
Marzena Kamińska, Tomasz Ciszewski, Karolina Łopacka-Szatan et al. · 2015 · Menopausal Review · 366 citations
Breast cancer is the most frequently diagnosed neoplastic disease in women around menopause often leading to a significant reduction of these women's ability to function normally in everyday life. ...
Male breast carcinoma
Paul E. Goss, Caroline Reid, Melania Pintilie et al. · 1999 · Cancer · 326 citations
Compared with data from female breast carcinoma patients, 5-year OS for this series was low; however, when these patients were separated by lymph node status, survival was similar for those with ax...
Incidence and Outcome of Male Breast Cancer: An International Population-Based Study
Hui Miao, Helena M. Verkooijen, Kee‐Seng Chia et al. · 2011 · Journal of Clinical Oncology · 254 citations
Purpose Male breast cancer is a rare disease with an incidence rate less than 1% of that of female breast cancer. Given its low incidence, few studies have assessed risk and prognosis. Methods This...
Reading Guide
Foundational Papers
Start with Giordano et al. (2004, 776 citations) for SEER-based survival benchmarks, then Anderson et al. (2009, 479 citations) for male-female comparisons, and Goss et al. (1999, 326 citations) for lymph node-adjusted outcomes.
Recent Advances
Study Cardoso et al. (2017, 379 citations) for EORTC molecular characterization and Konduri et al. (2020, 399 citations) for updated epidemiology impacting survival.
Core Methods
Core methods include SEER registry analysis, Kaplan-Meier survival curves, Cox proportional hazards models, and population-based incidence-outcome linkages.
How PapersFlow Helps You Research Survival Outcomes Male Breast Cancer
Discover & Search
Research Agent uses searchPapers and citationGraph to map Giordano et al. (2004, 776 citations) as the top-cited hub, linking to Anderson et al. (2009) and Miao et al. (2011) for survival comparisons. exaSearch uncovers population-based studies beyond SEER, while findSimilarPapers expands to international cohorts like Cardoso et al. (2017).
Analyze & Verify
Analysis Agent applies readPaperContent to extract 5-year survival rates from Giordano et al. (2004), then verifyResponse with CoVe checks claims against SEER data. runPythonAnalysis runs Kaplan-Meier survival curves on extracted data using pandas, with GRADE grading for evidence quality on prognostic factors.
Synthesize & Write
Synthesis Agent detects gaps in stage-adjusted survival models across papers, flagging contradictions in lymph node impacts (Goss et al., 1999 vs. Anderson et al., 2009). Writing Agent uses latexEditText and latexSyncCitations to draft prognosis tables, latexCompile for PDF reports, and exportMermaid for survival curve diagrams.
Use Cases
"Extract survival rates from Giordano 2004 and plot Kaplan-Meier curves by stage"
Research Agent → searchPapers(Giordano 2004) → Analysis Agent → readPaperContent → runPythonAnalysis(pandas survival plot) → matplotlib output with GRADE-verified rates.
"Write LaTeX review comparing male vs female survival from top 5 papers"
Research Agent → citationGraph(top papers) → Synthesis Agent → gap detection → Writing Agent → latexEditText(draft) → latexSyncCitations(Anderson 2009 et al.) → latexCompile(PDF review).
"Find code for male breast cancer prediction models in related repos"
Research Agent → paperExtractUrls(Cardoso 2017) → Code Discovery → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis(test model on SEER-like data).
Automated Workflows
Deep Research workflow conducts systematic review of 50+ male breast cancer papers, chaining searchPapers → citationGraph → DeepScan for 7-step survival data extraction with CoVe checkpoints. Theorizer generates hypotheses on prognostic factors from Giordano (2004) and Miao (2011) patterns. DeepScan verifies stage biases across cohorts step-by-step.
Frequently Asked Questions
What defines survival outcomes in male breast cancer?
Survival outcomes measure prognostic factors like stage, lymph node status, and 5-year overall survival rates, often worse in males due to late diagnosis (Giordano et al., 2004).
What methods analyze male breast cancer survival?
Population-based studies use SEER data for stage-specific rates and Cox models for hazard ratios, comparing to female cohorts (Anderson et al., 2009; Miao et al., 2011).
What are key papers on this topic?
Giordano et al. (2004, 776 citations) analyzes SEER survival; Anderson et al. (2009, 479 citations) compares sexes; Cardoso et al. (2017, 379 citations) details molecular subtypes.
What open problems exist?
Challenges include sparse molecular data, small cohorts, and unadjusted stage biases; future work needs multi-omics prediction models (Cardoso et al., 2017).
Research Male Breast Health Studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Survival Outcomes Male Breast Cancer with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Male Breast Health Studies Research Guide